Marizyme, Inc. (MRZM)

USD 0.01

(0.0%)

Revenue Summary of Marizyme, Inc.

  • Marizyme, Inc.'s latest annual revenue in 2023 was 645.81 Thousand USD , up 176.6% from previous year.
  • Marizyme, Inc.'s latest quarterly revenue in 2024 Q1 was 32.85 Thousand USD , down -78.18% from previous quarter.
  • Marizyme, Inc. reported a annual revenue of 233.48 Thousand USD in annual revenue 2022, up 11.04% from previous year.
  • Marizyme, Inc. reported a annual revenue of 210.27 Thousand USD in annual revenue 2021, up 6.67% from previous year.
  • Marizyme, Inc. reported a quarterly revenue of 32.85 Thousand USD for 2024 Q1, down -78.18% from previous quarter.
  • Marizyme, Inc. reported a quarterly revenue of 184.73 Thousand USD for 2023 Q2, up 43.24% from previous quarter.

Annual Revenue Chart of Marizyme, Inc. (2023 - 2007)

Created with Highcharts 11.1.0YearsRevenue200820102012201420162018202020220 USD10000000 USD20000000 USD30000000 USD

Historical Annual Revenue of Marizyme, Inc. (2023 - 2007)

Year Revenue Revenue Growth
2023 645.81 Thousand USD 176.6%
2022 233.48 Thousand USD 11.04%
2021 210.27 Thousand USD 6.67%
2020 197.13 Thousand USD 0.0%
2019 - USD -100.0%
2018 20.18 Thousand USD -80.05%
2017 101.17 Thousand USD -65.25%
2016 291.13 Thousand USD -28.59%
2015 407.7 Thousand USD 0.0%
2014 - USD 0.0%
2013 - USD -100.0%
2012 25.8 Million USD -6.86%
2011 27.7 Million USD 199577.33%
2010 13.87 Thousand USD -63.92%
2009 38.46 Thousand USD 21.85%
2008 31.56 Thousand USD 182.56%
2007 11.17 Thousand USD 0.0%

Peer Revenue Comparison of Marizyme, Inc.

Name Revenue Revenue Difference
Evofem Biosciences, Inc. 18.21 Million USD 96.455%
Neon Bloom, Inc. - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Qrons Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Skye Bioscience, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.475%
Adynxx, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 66.573%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 1.927%
Arch Therapeutics, Inc. 75.72 Thousand USD -752.847%
Burzynski Research Institute, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 95.906%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -3565.002%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 96.993%
Intellipharmaceutics International Inc. 65.72 Thousand USD -882.549%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 89.058%
Genus plc 668.8 Million USD 99.903%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.737%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -552.373%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -57.451%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -741.326%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -1534.217%
MultiCell Technologies, Inc. 49.32 USD -1309328.224%
ONE Bio Corp. 52.29 Million USD 98.765%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 98.701%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -1220.675%
Q BioMed Inc. 284.35 Thousand USD -127.116%
Emmaus Life Sciences, Inc. 29.59 Million USD 97.818%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.555%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD -15.797%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 70 Thousand USD -822.586%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.996%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -64545.646%
Enzolytics Inc. 52.79 Thousand USD -1123.218%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD -6.127%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.947%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -360.497%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD -4.604%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.923%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 35.272%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 98.664%
BioStem Technologies, Inc. 16.68 Million USD 96.129%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -173.001%
Regen BioPharma, Inc. 236.56 Thousand USD -173.001%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 52.826%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD -36.324%
SYBLEU INC 11.69 Thousand USD -5421.631%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 91.709%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -4867.769%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -1533.556%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 80.606%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 90.31%
IntelGenx Technologies Corp. 1.03 Million USD 37.843%
Gelesis Holdings, Inc. 25.76 Million USD 97.494%
CSL Limited 14.8 Billion USD 99.996%
Cellectis S.A. 755 Thousand USD 14.462%